Clinical Trials Sponsored by Merck Frosst-Schering Pharma, G.P

Total 5 results

University of British Columbia
Merck Frosst-Schering Pharma, G.P.

Completed

Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

HIV Infections | Hypercholesterolemia

Canada
Canadian Heart Research Centre
Merck Frosst Canada Ltd.; Schering-Plough

Completed

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE ) (GUIDE)

Cardiovascular Diseases

Canada
Sunnybrook Health Sciences Centre
Merck Frosst Canada Ltd.; Schering-Plough

Terminated

INdians Followed for INtensive Lipid Lowering Treatment and Its safetY (INFINITY)

Hypercholesterolemia

Canada
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG; Schering-Plough; Merck Serono...

Completed

Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV (CO13Hepavih)

Hepatitis C | HIV
Group Health Centre
Eli Lilly and Company; Merck Frosst Canada Ltd.; Sault Area Hospital; Algoma Community... and other collaborators

Completed

FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study

Osteoporosis

3

Subscribe